Skip to main content
SpringerLink
Log in

Fever and Abdominal Pain

  • Chapter
  • First Online:
Pediatric Autoimmunity and Transplantation

  • 315 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22(5):561–6.

    Article  Google Scholar 

  2. Atteritano M, David A, Bagnato G, Beninati C, Frisina A, Iaria C, Cascio A. Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci. 2012;16(10):1414–24.

    CAS  PubMed  Google Scholar 

  3. Wong K-F, Hui P-K, Chan JK, Chan Y-W, Ha S-Y. The acute lupus hemophagocytic syndrome. Ann Intern Med. 1991;114(5):387–90.

    Article  CAS  Google Scholar 

  4. Voskoboinik I, Sutton VR, Ciccone A, House CM, Chia J, Darcy PK, Yagita H, Trapani JA. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood. 2007;110(4):1184–90.

    Article  CAS  Google Scholar 

  5. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34(5):1133–8.

    PubMed  Google Scholar 

  6. Sawhney S, Woo P, Murray K. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85(5):421–6.

    Article  CAS  Google Scholar 

  7. Stephan J, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology. 2001;40(11):1285–92.

    Article  CAS  Google Scholar 

  8. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.

    Article  Google Scholar 

  9. Zur Stadt U, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka G, Hennies HC. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat. 2006;27(1):62–8.

    Article  CAS  Google Scholar 

  10. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002;14(5):548–52.

    Article  CAS  Google Scholar 

  11. Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, Andrews DM, Voskoboinik I, Trapani JA. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212(3):307–17.

    Article  CAS  Google Scholar 

  12. Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr. 2009;221(05):278–85.

    Article  CAS  Google Scholar 

  13. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 2004;50(3):689–98.

    Article  Google Scholar 

  14. Saltzman RW, Monaco-Shawver L, Zhang K, Sullivan KE, Filipovich AH, Orange JS. Novel mutation in syntaxin-binding protein 2 (STXBP2) prevents IL-2-induced natural killer cell cytotoxicity. J Allergy Clin Immunol. 2012;129(6):1666.

    Article  CAS  Google Scholar 

  15. Spessott WA, Sanmillan ML, McCormick ME, Patel N, Villanueva J, Zhang K, Nichols KE, Giraudo CG. Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion. Blood. 2015;125(10):1566–77.

    Article  CAS  Google Scholar 

  16. Zhang M, Bracaglia C, Prencipe G, Bemrich-Stolz CJ, Beukelman T, Dimmitt RA, Chatham WW, Zhang K, Li H, Walter MR, De Benedetti F, Grom AA, Cron RQ. A Heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis. J Immunol. 2016;196:2492–503.

    Google Scholar 

  17. Zhang X-Y, Ye X-W, Feng D-X, Han J, Li D, Zhang C. Hemophagocytic lymphohistiocytosis induced by severe pandemic influenza A (H1N1) 2009 virus infection: a case report. Case Rep Med. 2011;2011:951910.

    Article  Google Scholar 

  18. Sullivan KE, Delaat CA, Douglas SD, Filipovich AH. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res. 1998;44(4):465–8.

    Article  CAS  Google Scholar 

  19. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2004;7(1):1.

    Google Scholar 

  20. Caiello I, Minnone G, Holzinger D, Vogl T, Prencipe G, Manzo A, De Benedetti F, Strippoli R. IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases. PLoS One. 2014;9(10):e107886.

    Article  Google Scholar 

  21. Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep. 2014;16(9):439.

    Article  Google Scholar 

  22. Schulert GS, Grom AA. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol. 2014;28(2):277–92.

    Article  Google Scholar 

  23. Weaver LK, Behrens EM. Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol. 2014;26(5):562.

    Article  CAS  Google Scholar 

  24. Chen C, Huang Y, Jaing T, Hung I, Yang C, Chang L, Lin T. Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect. 2004;37(3):157.

    PubMed  Google Scholar 

  25. Elazary AS, Wolf DG, Amir G, Avni B, Rund D, Yehuda DB, Sviri S. Severe Epstein–Barr virus-associated hemophagocytic syndrome in six adult patients. J Clin Virol. 2007;40(2):156–9.

    Article  Google Scholar 

  26. Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 2007;29(8):569–73.

    Article  Google Scholar 

  27. Milone MC, Tsai DE, Hodinka RL, Silverman LB, Malbran A, Wasik MA, Nichols KE. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell–directed therapy. Blood. 2005;105(3):994–6.

    Article  CAS  Google Scholar 

  28. Henter J-I, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367–73.

    Article  CAS  Google Scholar 

  29. Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol. 2011;17(1):23–7.

    Article  Google Scholar 

  30. Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol. 2008;4(11):615–20.

    Article  CAS  Google Scholar 

  31. Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, Van Rossum MA, Cortis E, Pardeo M, Miettunen PM, Janow G. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011;63(2):545–55.

    Article  CAS  Google Scholar 

  32. Record JL, Beukelman T, Cron RQ. Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series. J Rheumatol. 2011;38(1):180–1.

    Article  Google Scholar 

  33. Cron RQ, Chatham WW. Development of spondyloarthropathy following episodes of macrophage activation syndrome in children with heterozygous mutations in haemophagocytic lymphohistiocytosis-associated genes. Clin Exp Rheumatol. 2016;34(5):953.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA

    Esraa M. Eloseily & Randy Q. Cron

  2. Division of Rheumatology, Department of Pediatrics, Assiut University Children’s Hospital, Assiut, Egypt

    Esraa M. Eloseily

Authors
  1. Esraa M. Eloseily
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Randy Q. Cron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Randy Q. Cron .

Editor information

Editors and Affiliations

  1. Student’s Scientific Research Center (SSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Farzaneh Rahmani

  2. Department of Immunology, School of Medicine, Research Center for Immunodeficiencies (RCID), Children’s Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Eloseily, E.M., Cron, R.Q. (2020). Fever and Abdominal Pain. In: Rahmani, F., Rezaei, N. (eds) Pediatric Autoimmunity and Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-030-26280-8_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26280-8_49

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26279-2

  • Online ISBN: 978-3-030-26280-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation